Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-19

Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of azilsartan medoxomil in African American adults with essential hypertension. The study is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edarbi (azilsartan medoxomil)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19